# Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis

> **NCT03851835** · PHASE3 · COMPLETED · sponsor: **University of Calgary** · enrollment: 1030 (actual)

## Conditions studied

- Acute Gastroenteritis
- Viral Illness
- Vomiting
- Diarrhea

## Interventions

- **DRUG:** Ondansetron Oral Solution
- **DRUG:** Oral Placebo

## Key facts

- **NCT ID:** NCT03851835
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-14
- **Primary completion:** 2024-06-27
- **Final completion:** 2024-07-06
- **Target enrollment:** 1030 (ACTUAL)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851835, "Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03851835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*